241 related articles for article (PubMed ID: 34261777)
1. Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes?
De Luca L; Rubboli A; Bolognese L; Uguccioni M; Lucci D; Blengino S; Campodonico J; Meynet I; Brach Prever SM; Di Lenarda A; Gabrielli D; Gulizia MM;
Open Heart; 2021 Jul; 8(2):. PubMed ID: 34261777
[TBL] [Abstract][Full Text] [Related]
2. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY
Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the CHA
Peng H; Sun Z; Chen H; Zhang Y; Ding X; Zhao XQ; Li H
Am J Cardiol; 2019 Aug; 124(4):476-484. PubMed ID: 31235063
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
[TBL] [Abstract][Full Text] [Related]
5. Post-discharge antithrombotic management and clinical outcomes of patients with new-onset or pre-existing atrial fibrillation and acute coronary syndromes undergoing coronary stenting: Follow-up data of the MATADOR-PCI study.
De Luca L; Di Lenarda A; Rubboli A; Bolognese L; Gonzini L; Fortuni F; Navazio A; Poletti F; Ledda A; Urbinati S; Gabrielli D; Gulizia MM;
Eur J Intern Med; 2021 Jun; 88():28-34. PubMed ID: 33838988
[TBL] [Abstract][Full Text] [Related]
6. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.
Zeymer U; Annemans L; Danchin N; Pocock S; Newsome S; Van de Werf F; Medina J; Bueno H
Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):121-129. PubMed ID: 29611427
[TBL] [Abstract][Full Text] [Related]
7. Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry.
Proietti M; Airaksinen KEJ; Rubboli A; Schlitt A; Kiviniemi T; Karjalainen PP; Lip GY;
Am Heart J; 2017 Aug; 190():86-93. PubMed ID: 28760217
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials.
Gargiulo G; Cannon CP; Gibson CM; Goette A; Lopes RD; Oldgren J; Korjian S; Windecker S; Esposito G; Vranckx P; Valgimigli M
Eur Heart J Cardiovasc Pharmacother; 2021 Apr; 7(FI1):f50-f60. PubMed ID: 33119069
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic strategy variability in ATrial fibrillation and obstructive coronary disease revascularized with PCI-rationale and study design of the prospective observational multicenter AVIATOR 2 registry.
Chandrasekhar J; Mastoris I; Baber U; Sartori S; Schoos M; Bansilal S; Dangas G; Mehran R
Am Heart J; 2015 Dec; 170(6):1234-42. PubMed ID: 26678646
[TBL] [Abstract][Full Text] [Related]
10. The Predictive Value of CHA
Borovac JA; Kwok CS; Mohamed MO; Fischman DL; Savage M; Alraies C; Kalra A; Nolan J; Zaman A; Ahmed J; Bagur R; Mamas MA
Cardiovasc Revasc Med; 2021 Aug; 29():61-68. PubMed ID: 32828675
[TBL] [Abstract][Full Text] [Related]
11. Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients.
Galli M; Andreotti F; Porto I; Crea F
Europace; 2020 Apr; 22(4):538-546. PubMed ID: 31942971
[TBL] [Abstract][Full Text] [Related]
12. A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation.
Mai L; Wu Y; Luo J; Liu X; Zhu H; Zheng H; Liang G; Zhang Y; Huang Y
BMJ Open; 2019 Sep; 9(9):e031180. PubMed ID: 31530618
[TBL] [Abstract][Full Text] [Related]
13. Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis.
Goette A; Eckardt L; Valgimigli M; Lewalter T; Laeis P; Reimitz PE; Smolnik R; Zierhut W; Tijssen JG; Vranckx P
Clin Res Cardiol; 2021 Jun; 110(6):831-840. PubMed ID: 33098470
[TBL] [Abstract][Full Text] [Related]
14. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M
JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085
[TBL] [Abstract][Full Text] [Related]
15. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of ST-segment elevation myocardial infarction in patients with atrial fibrillation, prior stenting and long-standing chronic coronary syndrome.
Franchina AG; Calderone D; D'Arrigo P; Ingala S; Milluzzo RP; Greco A; Spagnolo M; Tamburino C; Capodanno D
Cardiol J; 2020; 27(1):8-15. PubMed ID: 31960945
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics, management and outcomes of patients with acute coronary syndrome and atrial fibrillation: real-world data from two nationwide registries in Italy.
Lucà F; Caretta G; Vagnarelli F; Marini M; Iorio A; Di Fusco SA; Pozzi A; Gabrielli D; Colivicchi F; De Luca L; Gulizia MM
J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):99-105. PubMed ID: 31923052
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
Sutton NR; Seth M; Ruwende C; Gurm HS
J Am Coll Cardiol; 2016 Aug; 68(9):895-904. PubMed ID: 27561762
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.
Harskamp RE; Fanaroff AC; Lopes RD; Wojdyla DM; Goodman SG; Thomas LE; Aronson R; Windecker S; Mehran R; Granger CB; Alexander JH
J Am Coll Cardiol; 2022 Feb; 79(5):417-427. PubMed ID: 35115097
[TBL] [Abstract][Full Text] [Related]
20. An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial.
Lopes RD; Vora AN; Liaw D; Granger CB; Darius H; Goodman SG; Mehran R; Windecker S; Alexander JH
Am Heart J; 2018 Jun; 200():17-23. PubMed ID: 29898844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
